Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

657 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement.
Carroll JD, Mack MJ, Vemulapalli S, Herrmann HC, Gleason TG, Hanzel G, Deeb GM, Thourani VH, Cohen DJ, Desai N, Kirtane AJ, Fitzgerald S, Michaels J, Krohn C, Masoudi FA, Brindis RG, Bavaria JE. Carroll JD, et al. Among authors: kirtane aj. J Am Coll Cardiol. 2020 Nov 24;76(21):2492-2516. doi: 10.1016/j.jacc.2020.09.595. J Am Coll Cardiol. 2020. PMID: 33213729 Free article. Review.
Comparison of effects of bare metal versus drug-eluting stent implantation on biomarker levels following percutaneous coronary intervention for non-ST-elevation acute coronary syndrome.
Gibson CM, Karmpaliotis D, Kosmidou I, Murphy SA, Kirtane AJ, Budiu D, Ray KK, Herrmann HC, Lakkis N, Kovach R, French W, Blankenship J, Lui HH, Palabrica T, Jennings LK, Cohen DJ, Morrow DA; TIMI Study Group. Gibson CM, et al. Among authors: kirtane aj. Am J Cardiol. 2006 May 15;97(10):1473-7. doi: 10.1016/j.amjcard.2005.12.037. Epub 2006 Mar 29. Am J Cardiol. 2006. PMID: 16679086 Clinical Trial.
Correlates of bleeding events among moderate- to high-risk patients undergoing percutaneous coronary intervention and treated with eptifibatide: observations from the PROTECT-TIMI-30 trial.
Kirtane AJ, Piazza G, Murphy SA, Budiu D, Morrow DA, Cohen DJ, Peterson E, Lakkis N, Herrmann HC, Palabrica TM, Gibson CM; TIMI Study Group. Kirtane AJ, et al. J Am Coll Cardiol. 2006 Jun 20;47(12):2374-9. doi: 10.1016/j.jacc.2005.09.080. Epub 2006 May 30. J Am Coll Cardiol. 2006. PMID: 16781361 Free article. Clinical Trial.
Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30).
Gibson CM, Kirtane AJ, Morrow DA, Palabrica TM, Murphy SA, Stone PH, Scirica BM, Jennings LK, Herrmann HC, Cohen DJ, McCabe CH, Braunwald E; TIMI Study Group. Gibson CM, et al. Among authors: kirtane aj. Am Heart J. 2006 Oct;152(4):756-61. doi: 10.1016/j.ahj.2006.04.016. Am Heart J. 2006. PMID: 16996854
Comparison of outcomes using sirolimus-eluting stenting in diabetic versus nondiabetic patients with comparison of insulin versus non-insulin therapy in the diabetic patients.
Kumar R, Lee TT, Jeremias A, Ruisi CP, Sylvia B, Magallon J, Kirtane AJ, Bigelow B, Abrahamson M, Pinto DS, Ho KK, Cohen DJ, Carrozza JP Jr, Cutlip DE. Kumar R, et al. Among authors: kirtane aj. Am J Cardiol. 2007 Oct 15;100(8):1187-91. doi: 10.1016/j.amjcard.2007.05.038. Epub 2007 Aug 2. Am J Cardiol. 2007. PMID: 17920355
Gender-specific outcomes after sirolimus-eluting stent implantation.
Solinas E, Nikolsky E, Lansky AJ, Kirtane AJ, Morice MC, Popma JJ, Schofer J, Schampaert E, Pucelikova T, Aoki J, Fahy M, Dangas GD, Moses JW, Cutlip DE, Leon MB, Mehran R. Solinas E, et al. Among authors: kirtane aj. J Am Coll Cardiol. 2007 Nov 27;50(22):2111-6. doi: 10.1016/j.jacc.2007.06.056. Epub 2007 Nov 13. J Am Coll Cardiol. 2007. PMID: 18036446 Free article. Clinical Trial.
Value of drug-eluting stents in cardiac transplant recipients.
Gupta A, Mancini D, Kirtane AJ, Kaple RK, Apfelbaum MA, Kodali SK, Marboe C, Leon MB, Moses JW, Rabbani LE. Gupta A, et al. Among authors: kirtane aj. Am J Cardiol. 2009 Mar 1;103(5):659-62. doi: 10.1016/j.amjcard.2008.10.042. Epub 2009 Jan 12. Am J Cardiol. 2009. PMID: 19231329
657 results